KellyEliseDooleyMD
Infectious Disease • Nashville, TNAssistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Dooley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Childrens Way
Nashville, TN 37232Phone+1 615-936-2000
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2005 - 2008- Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
Duke University School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2002 - Present
TN State Medical License 2022 - 2025
MD State Medical License 2006 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers Start of enrollment: 2009 Dec 01
- Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers Start of enrollment: 2010 Apr 01
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Patrick P J Phillips
American Journal of Respiratory and Critical Care Medicine. 2024-12-01 - Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid
Nature Communications. 2024-10-30 - Advancing the chemotherapy of tuberculous meningitis: a consensus view.Sean Wasserman, Joseph Donovan, Evelyne Kestelyn, James A Watson, Robert E Aarnoutse
The Lancet. Infectious Diseases. 2024-09-26
Journal Articles
- State of the Art Review of HIV‐TB Coinfection in Special PopulationsEthel D Weld, Kelly E Dooley, Clinical Pharmacology & Therapeutics
Press Mentions
Johns Hopkins School of Medicine Among Clinical Trial Sites Testing COVID-19 TherapiesNovember 18th, 2020
Johns Hopkins Researchers to Present Latest Findings on TB and HIV at CROI 2019March 7th, 2019
Tip Sheet: Johns Hopkins Researchers Present at Annual CROI MeetingMarch 1st, 2018
Grant Support
- PK/PD Issues In The Use Of New Therapies For The Treatment Of TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2012
Other Languages
- French
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kelly-dooley
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
